Cargando…
Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort
Pulmonary arterial hypertension (PAH) is a devastating complication of systemic sclerosis (SSc). Screening for PAH in SSc has increased detection, allowed early treatment for PAH and improved patient outcomes. Blood-based biomarkers that reliably identify SSc patients at risk of PAH, or with early d...
Autores principales: | Bauer, Yasmina, de Bernard, Simon, Hickey, Peter, Ballard, Karri, Cruz, Jeremy, Cornelisse, Peter, Chadha-Boreham, Harbajan, Distler, Oliver, Rosenberg, Daniel, Doelberg, Martin, Roux, Sebastien, Nayler, Oliver, Lawrie, Allan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276065/ https://www.ncbi.nlm.nih.gov/pubmed/33334933 http://dx.doi.org/10.1183/13993003.02591-2020 |
Ejemplares similares
-
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis
por: Bauer, Yasmina, et al.
Publicado: (2017) -
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
por: Coghlan, J Gerry, et al.
Publicado: (2014) -
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study
por: Visovatti, Scott H, et al.
Publicado: (2014) -
A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat
por: Remenova, Tatiana, et al.
Publicado: (2015) -
Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data
por: Hickey, Peter M., et al.
Publicado: (2018)